Latest
PFE
Headlines
Anadys hopes positive data for its hepatitis C drug will attract a deep-pocketed partner to fund further development.
11:43AM 01/08/09
Large repurchases make these stocks to watch.
9:07AM 01/08/09
Dan Fitzpatrick examines three stocks viewed on Fast Money. Today's stocks include Johnson & Johnson, Novellus, and Monsanto.
08:14AM 01/08/09
Here is a list of potential acquisition targets for the world's largest drugmaker.
8:03AM 01/08/09
The company says the discussions are at a preliminary stage.
6:24PM 01/07/09
Adam Feuerstein looks at Pfizer's potential buys and staff members look at analysts' upgrades and downgrades.
11:59AM 01/07/09
Pfizer's looking to buy and it's about time says Stephanie Link, Director of Research for Cramer's Action Alerts Plus Portfolio, now find out what investors should buy.
10:47AM 01/07/09
U.S. political leaders must confront the ugly reality that the most fundamental economic problem America faces is a severe lack of private savings.
12:29PM 01/06/09
Here's what Jim Cramer's had to say about Pfizer lately.
7:06AM 01/06/09
Endo will acquire Indevus for $370 million, or $4.50 per share.
5:16PM 01/05/09
Understanding the Market
Our Experts' Take at RealMoney for Pfizer Incorporated
For the most conservative of investors, here are some super-safe dividend payers.
8:59AM 01/08/09
The estimates are all way too high, but the charts look pretty good. What to do?
7:21AM 01/08/09
More Experts' Takes on PFE
More popular tickers are indicated by scale.



